Who is affected and how:

• Individuals purchasing coverage in the individual marketplace and people enrolled in qualified Exchange plans will be directly affected: they may see lower premiums where reinsurance is used, higher subsidy amounts under a gold benchmark, lower out‑of‑pocket spending because of the new annual cap, and access to a federal public plan alternative that must cover abortion and broad benefits.

• Health insurers/issuers will face new market rules: a federal public plan entering the market, state options to receive reinsurance payments or reduce enrollee cost sharing, changes to the subsidy benchmark (which changes demand and premium dynamics), and stronger federal/state rate review and enforcement. Insurers will need to adapt pricing, filings, and possibly provider payment arrangements.

• Employers and employees: Employers will see a new public plan option that may be offered in small and large group markets; certain employers must refer full‑time employees to ACA navigators. Employer plan design decisions and competition with the public option may change employer offerings and employee take‑up.

• Health care providers and hospitals: Payment rates and payment methodologies could be affected through Secretary-set payment rules for the public plans and through changed insurer networks or reimbursement practices if the public plan or subsidy changes alter market dynamics.

• State insurance regulators and State governments: States will be asked to administer or participate in the reinsurance/affordability program and may adopt stronger rate review standards; regulators will coordinate with HHS/NAIC and may be assigned primary rate review responsibility in some markets.

• Federal agencies and budgets: HHS/CMS will need to conduct major rulemaking and administration of the public plans, the OOP cap, and reinsurance program. The Treasury appropriation of $30 billion for FY2026–2028 has a direct budgetary effect; other costs and savings will depend on implementation choices and market responses.

Net effects and tradeoffs:

• Consumers could benefit from lower OOP costs and stronger protections against excessive rate increases and from expanded coverage of reproductive services. However, market responses (insurer pricing, plan participation, provider contracting) are uncertain and will shape premium and network outcomes.
• States gain flexibility to stabilize markets via reinsurance but will need administrative capacity to implement program elements and overseen rate review changes.
• The measure creates sizable federal involvement in commercial markets (public plan entry, subsidy recalibration, reinsurance funding), making market transitions complex and politically contentious.